Also listed on Pulmokine, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 9, 2034 · High confidence
20-year base term ends Jan 9, 2034
Jan 9, 2014
Jan 9, 2034
Nov 14, 2017
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 9, 2014, when application PCT/US2014/010778, the earliest non-provisional in its chain, was filed (this one was filed Jul 9, 2015) | Jan 9, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,925,184) | resolves to Jan 9, 2034, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 9, 2034 | High confidence |
This family
| Application PCT/US2014/010773 | PCT application no patent term | no patent term |
| Application PCT/US2014/010778 | PCT application no patent term | no patent term |
| Application 14/760,165 | Abandoned not computed | not computed |
| US 9,815,815 | this patent Jan 2034 | Jan 2034 |
| US 10,246,438 | In force Jan 2034 | Jan 2034 |
| US 10,532,994 | In force Jan 2034 | Jan 2034 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 18, 2015 Reel 37069, frame 267 | Pulmokine, Inc. | Gilead Sciences, Inc. | Assignment of Assignor's Interest |
| Nov 21, 2016 Reel 40392, frame 952 | Pulmokine, Inc. | Pulmokine, Inc.; Gilead Sciences, Inc. | Assignment of Assignor's Interest |
| Nov 21, 2016 reel/frame not recorded | Pulmokine, Inc. | Pulmokine, Inc. | Assignment of Assignor's Interest |
| Nov 21, 2016 reel/frame not recorded | Pulmokine, Inc. | Gilead Sciences, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 9,925,184, ends no earlier than this term, so it caps nothing.